d) Distribution of total treatment time, measured in days, as recorded in individuals with measurements from both survey and EHR
Porque son perfiles regulatorios distintos
The same preclinical program reported that weight loss persisted for roughly 43 days after the last dose in animal models a durability signal that helped justify moving the compound into human Phase 1 and Phase 1b studies, the latter published in The Lancet in 2022 in a multicenter, placebo-controlled trial in people with type 2 diabetes
One more thing that trips people up: you generally don't want to re-refrigerate a pen that's been at room temperature for a while, then warm it, then chill it again
Another promising aspect is semaglutide is already widely used in general medical settings which can potentially increase accessibility and further aim to reduce stigma often associated with AUD treatments. The studys limitations such as small sample size, short study duration, and the fact that participants were not actively seeking treatment may suggest that the results may not fully translate to a real-world clinical setting, he continued
